A Study of Rucaparib and Nivolumab in People With Leiomyosarcoma
Status:
Recruiting
Trial end date:
2022-11-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out whether combining the study drugs rucaparib and
nivolumab may be an effective treatment for advanced and/or metastatic LMS, and whether the
study treatment works as well as the standard chemotherapy for this type of cancer.